HUNTSVILLE, Utah (PRWEB)
April 15, 2020

Pawzitivity Pet Products, a company that currently owns brands Vet Naturals and Senior Pups has announced that they have acquired two more companies that are in the pet products industry, Ruff Trade Dog and K9 Nature Supplements.

This move comes at a time where demand for premium pet care products is increasing and expected to continue to experience strong growth over the next few years. One report by Edge by Ascential suggests that consumers are increasingly seeing their pets as family members, and are prepared to spend more on pet food and products that are healthy, nutritious and improve living conditions.

“Right now, we’re seeking high-quality products with great brand recognition and reputation, and adding them to VetNaturals.com,” said Gary Nealon, Co-Owner of Pawzitivity Pet Products. “That will allow us to provide the highest quality products to our customers and their furry friends.”

The Ruff Trade Dog acquisition allows the Pawzitivity Pet Products brand to expand their reach even further, adding dog grooming and care supplies to the list of products that they offer. Ruff Trade Dog currently supplies all-natural and handmade dog grooming products, some of which have been featured in the BarkShop –a popular subscription service for dog products.

Currently, Ruff Trade Dog is an Etsy-based company, but Nealon has plans to expand it. There’s a new website in the works, and even plans to add new products soon.

“Finding all-natural, gentle dog grooming products can be a challenge, but we’re committed to sourcing the very best to ensure the health of our pets,” said Nealon.

The acquisition of K9 Nature Supplements also aligns well with the Pawzitivity Pet Products mission of supplying the best pet products possible.

K9 Nature Supplements provides nutritional supplements for dogs of every age and breed. The company is committed to ensuring that each product they provide is of the highest quality. Their supplements are designed to give dogs the nutrition they need to stay strong and healthy throughout all stages of life.

Pet products and pet supplies are a growing industry. Sixty-seven percent of all U.S. households own a pet, and according to the American Pet Products Association (APPA), in 2019, $95.7 billion was spent on pets in the U.S., with 38.4 billion being spent on pet food and treats alone. This figure is estimated to grow to $99.0 billion in 2020.

“We’ve seen strong interest in safe and healthy pet products,” said Nealon, “And as committed pet parents ourselves, we understand the important role that pets play in our lives. Each of our products is selected carefully, with the overall goal of making our pets’ lives as happy and healthy as possible.”

References:

Vet Naturals: https://vetnaturals.com/

Senior Pups: https://www.seniorpups.com/

K9 Supplements https://k9naturesupplements.com/

Ruff Trade Dog: https://www.etsy.com/shop/RuffTradeDog

American Pet Products Association: https://www.americanpetproducts.org/press_industrytrends.asp

Edge by Ascential: Household and Pet Care Consumer Packaged Goods report:

https://www.ascentialedge.com/insights/rise-pet-humanization-trend-drives-global-sales-premium-pet-care-products

About Vet Naturals:    

Vet Naturals is a pet supplement company that provides high-quality vet-recommended supplements to pet owners across the country. The company is committed to supplying products that are free from fillers, by-products, artificial colors, and flavors, and aims to provide pet owners with solutions that will help their dogs to have the best quality of life possible. Visit their website at https://vetnaturals.com/ to learn more.

About Pawzitivity Pet Products:

Pawzitivity Pet Products owns brand names Vet Naturals and Senior Pups. Their mission is to supply the best pet products in the world, from all-natural grooming supplies to supplements that contain only the highest quality ingredients. Their goal is to provide pet owners with solutions to help them care for their dogs throughout every stage of their lives.

Share article on social media or email:

RoosterBio Inc

“With the assistance of this award, this team solved significant regenerative medicine product and process development challenges, and we are better equipped today to fuel the rapid commercialization of scalable regenerative cure”- Jon Rowley, PhD, Founder and Chief Product Officer of RoosterBio

FREDERICK, Md. (PRWEB)
April 15, 2020

RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess systems, announces that the Medical Technology Enterprise Consortium (MTEC) recognized a multi-institution team with a “Prototype of the Year” award at MTEC’s 4th Annual Membership Meeting in March. The Regenerative Medicine (RegenMed) biomanufacturing collaboration had created a team initiative led by GenCure, a subsidiary of BioBridge Global, along with StemBioSys, the U.S. Army Institute of Surgical Research, and RoosterBio to build standardized and scalable RegenMed manufacturing solutions. MTEC, a non-profit government funded technology consortium, operates to confront the problems of wounded warriors with advanced biomedical solutions, including those for massive tissue and organ damage.

MTEC’s “Prototype of the Year” award spotlights breakthroughs developed by RoosterBio and its collaborators since MTEC’s 2016 assigned contract of $7.8M to standardize large-scale manufacturing capabilities for clinical grade hMSCs. Clinical applications of this new platform are translatable towards diverse RegenMed-targetable indications with scalable, off-the-shelf systems. This team’s success will facilitate broad adoption of cell manufacturing technology to empower product developers solving real world health challenges. Access to this scalable production platform, including hMSC starting and ancillary production materials, is available through RoosterBio’s commercial channels.

In response to the RFP titled “Biomanufacturing for Regenerative Medicine,” the team executed on its project titled “Commercial Scale-Up of Bone Marrow-Derived Mesenchymal Stem Cells for Regenerative Medicine.” This application was crafted to develop and technology-transfer an hMSC manufacturing process that was scalable, was completely xeno-fee, maintained hMSC quality attributes across platforms, and could be transferred to a cGMP production facility. This initiative successfully demonstrated across all milestones that the scalable bioreactor process could effectively bridge these wide-ranging production scales while maintaining product quality.

Specifically, as a partner on this team, RoosterBio helped to pioneer:

• 
  A completely xeno-free (XF) fed-batch microcarrier-based expansion process for hMSCs that scaled to a 50L culture volume, along with associated closed system and automated downstream processing; (HERE, link to related scientific poster presented at ISCT 2019)
• A commercialized cGMP-grade, xeno-free fed-batch bioprocess media system along with bioprocess recommendations specific for hMSC working cell banks, so that institutions with aims to deploy hMSCs within therapeutic product development could have rapid access to scalable manufacturing platforms; also,
• The complete system achieved two to three-fold above target cell yields and productivity metrics unparalleled with other systems, and this was transferred to GenCure’s contract manufacturing business unit for customer implementation under cGMP.

MTEC’s contract allowed the collaboration partners to show that hMSCs could successfully be manufactured at commercially relevant scales and still meet all their quality assurance benchmarks across the jump in manufacturing platforms. Becky Butler Cap, Chief Operating Officer of GenCure, credited strong team performance for this award, “We began this project with a shared vision and sets of complementary skills that allowed us to address together what none of us could have done independently. Together, we have created new capabilities and opportunities for the industry.”

Jon Rowley, PhD, Founder and Chief Product Officer of RoosterBio said, “With the assistance of this award, this team solved significant regenerative medicine product and process development challenges, and we are better equipped today to fuel the rapid commercialization of scalable regenerative cures.”

Since the MTEC contract ended in 2019, RoosterBio has been leveraging the work performed with bone marrow-derived hMSCs into other areas. hMSC-derived extracellular vesicles (EVs) or exosomes are a new and exciting class of therapies that also require large scale bioproduction. Accordingly, RoosterBio has adapted the hMSC production platform into an hMSC-EV manufacturing platform (HERE, link to related data poster). RoosterBio has also extended this technology to umbilical cord-derived hMSC systems, extending the therapeutic cell applications to more cell types (HERE, link to related 2020 blog entry showing data). Additional desirable advancements are to increase hMSC yields to beyond one billion cells per liter, as well as to further scale the 50L system to several hundred liters to achieve log enhancements in productivity and product yields.

About RoosterBio, Inc.

RoosterBio, Inc. is a privately held cell manufacturing platform technology company focused on accelerating the development of a sustainable Regenerative Medicine industry, one customer at a time. RoosterBio’s products are high-volume, cost-effective, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how living cells are purchased, expanded, and used in development, leading to marked time and cost savings for customers. RoosterBio’s innovative products and collaborative relationships are ushering in a new era of productivity and standardization into the field. Visit http://www.roosterbio.com.

Share article on social media or email:

Our beautiful shop in Bellflower is clean and fully stocked with the best products in the industry.

Our goal is to provide our patients with high quality, compassionate medicines that our earth provides. We address your entire body, mind and spirit.

BELLFLOWER, Calif. (PRWEB)
April 15, 2020

The Medicine Woman is proud to have obtained the first cannabis license for manufacturing, delivery and dispensary in the city of Bellflower. And, the first to operate and be owned by a woman.

“Our goal is to provide our patients with high quality, compassionate medicines that our earth provides. We address your entire body, mind and spirit,” explained Charis Burrett, owner of The Medicine Woman. “We go above and beyond to take the time to care for our customers and create quality products.”

Due to the COVID-19 pandemic, the entire team at The Medicine Woman is focusing on shop cleanliness and providing customers with a safe and clean environment. All of the budtenders and staff are required to wear masks and gloves, and free masks are also provided to any customer who does not have one.

The Medicine Woman started as a California nonprofit in 2015, offering over 300+ products to our extensive patient network. Today, we offer the Medicine Woman products and hundreds of other products from leading brands at our brick-and-mortar location in Bellflower at 9058 Rose St.

The dispensary opened in early 2019, and since then, has been providing the highest quality and “nothing but the best” in cannabis and they are dedicated to creating awareness and fighting stigma outside of the cannabis industry. In addition to The Medicine Woman’s complete line of products including live resin and deluxe gold batteries, they also offer an eponymous line of CBD products, top-shelf flower and apparel including fashion-forward t-shirts, sweatshirts and hats with the iconic Medicine Woman logo.

You’ll also find many of the top cannabis brands throughout the shop, including all categories — flower, vape, concentrates, CBD, edibles, clones and other specialty products.

“We have nothing but the best in the industry,” Charis continued. “It takes a village and it takes a team, and that is what we have here.”

The entire staff at The Medicine Woman is trained, passionate and knowledgeable about all aspects of their cannabis offerings and dedicated to sharing that expertise with anyone who visits the store. Whether you know what you want or you need help with discovery, the experts at The Medicine Woman have got you.

“We are always working on communication with our clients and patients to find out what their needs are. We are dedicated to educating our clients and ensuring they have the information they need–whether it is for recreational or medicinal usage. Communication is really the key for us and helping people to get what they need out of cannabis. We are that liaison for them.”

Even if you know nothing about cannabis, The Medicine Woman is a place where you can get educated, ask questions and find out more without any judgment.

In celebration of the upcoming 4/20 holiday, The Medicine Woman will be giving away gift bags stocked full of products and other cool merchandise to the first 100 patients. Be sure to check out our upcoming article in the Los Angeles Business Journal’s 4/20 edition.

About The Medicine Woman

The Medicine Woman is committed to providing a full-spectrum of global plant medicines and destinations to benefit the health and wellness of our local communities. We are dedicated to giving our patients direct and safe access to the finest medicinal herbs from around the world, and to the compassionate care of California’s finest herbal practitioners. We are committed to offering products whose integrity and quality we consider “Nothing but the Best,” and we are seeking to revolutionize modern health care by providing natural, safe, effective and affordable remedies for our communities’ healthcare needs. The Medicine Woman’s core value is to educate our communities about the benefits of herbal medicine and other natural wellness based healthcare systems.

Share article on social media or email:

CLIFFSIDE PARK, N.J. (PRWEB)
April 15, 2020

Cliffside Park’s luxury condo development One Park has announced that it is donating a supply of face masks to its exclusive brokerage firm, NestSeekers, to help agents protect themselves during the COVID-19 outbreak. One Park’s developer, DMG Investments, has also created extra Matterport virtual tour and unit video resources to allow brokers to continue working while social distancing.

Since real estate agents work exclusively on commission, One Park is focused on helping ensure that the agents that sell and rent its units can have the opportunity to continue earning an income during the economic uncertainty brought about by the pandemic.

More information about One Park Condos can be found at: https://oneparkcondosnj.com/

About One Park

One Park, the premiere luxury condominium development located in Bergen County’s Cliffside Park, offers fourteen stories with two hundred four upscale units featuring expansive views of the New York City skyline and Hudson River. Units offer spacious living arrangements featuring from one to four bedrooms and up to 2,983 square feet of living space. Interior spaces boast gourmet kitchens with chef-caliber appliances, sanctuary-like bedroom suites, and spa-inspired master suite baths. One Park is a recognized leader in world class architecture and dramatic views in the Bergen County community.

One Park residents enjoy privileged amenities and a short commute to and from New York City. With amenities that rival New York City luxury buildings, including an outdoor movie theater, fitness center, golf simulator, children’s playroom, and pet spa, residents want for nothing. One Park residents have attentive twenty-four-hour doorman service and two options to accommodate their automobiles, including the recent addition of a luxury vehicle garage designed explicitly for low chassis vehicles like the Lamborghini and Ferrari. A resident-only shuttle service is also an option.

About DMG Investments

Headquartered in New York City at 100 Wall Street, DMG Investments LLC (“DMG”) was established in 2013.

DMG focuses on real estate acquisitions, development and management as well as financing. Leveraging the expertise of a team of dedicated real estate professionals with decades of experience creating and adding value for investors, DMG has amassed a portfolio of best-in-class assets across the US in dynamic markets in New York, New Jersey, Texas, Tennessee, Wisconsin, and South Carolina.

As the portfolio continues to grow, DMG is dedicated to providing amenities and services that enhance the livability of each project be it in the student housing, traditional multifamily or condominium sector. In the years to come, the goal of DMG is to become a global real estate enterprise with a world-class reputation for sustainable development and a business philosophy that emphasizes the importance of delivering value for investors, owners and residents.

Share article on social media or email: